In inflammatory breast cancer, which is a rare and aggressive type of breast cancer, a number of pathways such as the JAK/STAT, COX2, and IL6 pathways are activated, which have critical biological effects by supporting the escape of cancer cells from detection by the immune cells in the TME [48]. Here, IL6 is linked to inflammatory breast carcinoma.